<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"
                      "http://www.w3.org/TR/REC-html40/loose.dtd">
<HTML>
<HEAD>
<TITLE>extropians: ACE inhibitors &amp; hypoglycemic agents as LE drugs</TITLE>
<META NAME="Author" CONTENT="James Ganong (JGanong@webtv.net)">
<META NAME="Subject" CONTENT="ACE inhibitors &amp; hypoglycemic agents as LE drugs">
</HEAD>
<BODY BGCOLOR="#FFFFFF" TEXT="#000000">
<H1>ACE inhibitors &amp; hypoglycemic agents as LE drugs</H1>
<!-- received="Fri Jul  7 05:50:11 2000" -->
<!-- isoreceived="20000707115011" -->
<!-- sent="Fri, 7 Jul 2000 04:50:51 -0700 (PDT)" -->
<!-- isosent="20000707115051" -->
<!-- name="James Ganong" -->
<!-- email="JGanong@webtv.net" -->
<!-- subject="ACE inhibitors &amp; hypoglycemic agents as LE drugs" -->
<!-- id="6893-3965C41B-2033@storefull-135.iap.bryant.webtv.net" -->
<STRONG>From:</STRONG> James Ganong (<A HREF="mailto:JGanong@webtv.net?Subject=Re:%20ACE%20inhibitors%20&amp;%20hypoglycemic%20agents%20as%20LE%20drugs&In-Reply-To=&lt;6893-3965C41B-2033@storefull-135.iap.bryant.webtv.net&gt;"><EM>JGanong@webtv.net</EM></A>)<BR>
<STRONG>Date:</STRONG> Fri Jul 07 2000 - 05:50:51 MDT
<P>
<!-- next="start" -->
<UL>
<LI><STRONG>Next message:</STRONG> <A HREF="0463.html">Anders Sandberg: "Re: omega-point-deity (was: from Italy about exi)"</A>
<LI><STRONG>Previous message:</STRONG> <A HREF="0461.html">Robert J. Bradbury: "Re: Nanomedicine by R. Freitas available on the web"</A>
<!-- nextthread="start" -->
<LI><STRONG>Next in thread:</STRONG> <A HREF="0636.html">phil osborn: "Re: ACE inhibitors &amp; hypoglycemic agents as LE drugs"</A>
<LI><STRONG>Maybe reply:</STRONG> <A HREF="0636.html">phil osborn: "Re: ACE inhibitors &amp; hypoglycemic agents as LE drugs"</A>
<!-- reply="end" -->
<LI><STRONG>Messages sorted by:</STRONG> 
<A HREF="date.html#462">[ date ]</A>
<A HREF="index.html#462">[ thread ]</A>
<A HREF="subject.html#462">[ subject ]</A>
<A HREF="author.html#462">[ author ]</A>
</UL>
<HR NOSHADE><P>
<!-- body="start" -->
<P>
Several days ago, CYMM had asked about these medications &amp; their LE
<BR>
applications ( I just saw the post while playing email catchup, hence
<BR>
the delay);
<BR>
as a pharmacist, I have reflexive habit of answering drug-related
<BR>
questions, so:
<BR>
<P>ACE inhibitors are good for reducing mortality &amp; morbidity from
<BR>
cardiovascular
<BR>
disease, but other than this I know of no direct LE benefits.
<BR>
<P>Hypoglycemic agents might have some benefit in LE programs by reducing
<BR>
the formation of AGEs, but dietary modification is probably as effective
<BR>
for nondiabetics, without risking the adverse side effects.  The real
<BR>
promise lies with drugs like aminoguanidine that can reverse existing
<BR>
damage from AGEs.
<BR>
<P>Hope this helps.
<BR>
<P><!-- body="end" -->
<HR NOSHADE>
<UL>
<!-- next="start" -->
<LI><STRONG>Next message:</STRONG> <A HREF="0463.html">Anders Sandberg: "Re: omega-point-deity (was: from Italy about exi)"</A>
<LI><STRONG>Previous message:</STRONG> <A HREF="0461.html">Robert J. Bradbury: "Re: Nanomedicine by R. Freitas available on the web"</A>
<!-- nextthread="start" -->
<LI><STRONG>Next in thread:</STRONG> <A HREF="0636.html">phil osborn: "Re: ACE inhibitors &amp; hypoglycemic agents as LE drugs"</A>
<LI><STRONG>Maybe reply:</STRONG> <A HREF="0636.html">phil osborn: "Re: ACE inhibitors &amp; hypoglycemic agents as LE drugs"</A>
<!-- reply="end" -->
<LI><STRONG>Messages sorted by:</STRONG> 
<A HREF="date.html#462">[ date ]</A>
<A HREF="index.html#462">[ thread ]</A>
<A HREF="subject.html#462">[ subject ]</A>
<A HREF="author.html#462">[ author ]</A>
</UL>
<!-- trailer="footer" -->
<HR NOSHADE>
<P>
<SMALL>
<EM>
This archive was generated by <A HREF="http://www.hypermail.org/">hypermail 2b29</A> 
: <EM>Mon Oct 02 2000 - 17:34:07 MDT</EM>
</EM>
</SMALL>
</BODY>
</HTML>
